Citadel Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Buy
+40,200
New +$122K ﹤0.01% 11907
2025
Q4
Sell
-12,400
Closed -$52.5K 13235
2025
Q3
$52.5K Sell
12,400
-42,400
-77% -$160K ﹤0.01% 12176
2025
Q2
$116K Sell
54,800
-54,700
-50% -$81.8K ﹤0.01% 11211
2025
Q1
$134K Buy
109,500
+31,100
+40% +$43.6K ﹤0.01% 11046
2024
Q4
$101K Buy
78,400
+26,800
+52% +$64.2K ﹤0.01% 11469
2024
Q3
$142K Buy
51,600
+48,900
+1,811% +$120K ﹤0.01% 10634
2024
Q2
$6.1K Buy
+2,700
New +$8.2K ﹤0.01% 13358
2024
Q1
Sell
-4,400
Closed -$7.3K 14894
2023
Q4
$7.3K Buy
+4,400
New +$8.53K ﹤0.01% 13294
2023
Q3
Sell
-2,400
Closed -$3.46K 14598
2023
Q2
$3.46K Sell
2,400
-900
-27% -$1.53K ﹤0.01% 13690
2023
Q1
$6.93K Sell
3,300
-1,200
-27% -$1.94K ﹤0.01% 13772
2022
Q4
$5.08K Buy
+4,500
New +$5.99K ﹤0.01% 14036
2022
Q3
Sell
-10,700
Closed -$14K 13054
2022
Q2
$14K Buy
+10,700
New +$15.4K ﹤0.01% 12511
2021
Q4
Sell
-18,400
Closed -$71K 14198
2021
Q3
$71K Sell
18,400
-2,700
-13% -$9.15K ﹤0.01% 13145
2021
Q2
$68K Buy
+21,100
New +$75.1K ﹤0.01% 13180
2021
Q1
Sell
-10,000
Closed -$22K 13383
2020
Q4
$22K Buy
+10,000
New +$26.2K ﹤0.01% 10761
2020
Q1
Sell
-19,200
Closed -$55K 9813
2019
Q4
$55K Sell
19,200
-16,800
-47% -$58.4K ﹤0.01% 8729
2019
Q3
$132K Buy
36,000
+3,500
+11% +$12.7K ﹤0.01% 8354
2019
Q2
$135K Buy
+32,500
New +$141K ﹤0.01% 8406
2019
Q1
Sell
-20,300
Closed -$70K 9521
2018
Q4
$70K Sell
20,300
-15,400
-43% -$73.6K ﹤0.01% 8393
2018
Q3
$215K Sell
35,700
-13,400
-27% -$73.7K ﹤0.01% 8108
2018
Q2
$312K Buy
49,100
+31,300
+176% +$152K ﹤0.01% 7146
2018
Q1
$84K Sell
17,800
-2,800
-14% -$13K ﹤0.01% 7775
2017
Q4
$69K Buy
+20,600
New +$52.1K ﹤0.01% 7541
2015
Q4
Sell
-2,900
Closed -$7K 8875
2015
Q3
$7K Sell
2,900
-2,600
-47% -$6.13K ﹤0.01% 8568
2015
Q2
$15K Buy
+5,500
New +$16.6K ﹤0.01% 8284
2015
Q1
Sell
-6,000
Closed -$21K 8634
2014
Q4
$21K Sell
6,000
-8,100
-57% -$35.8K ﹤0.01% 7758
2014
Q3
$71K Buy
14,100
+6,800
+93% +$53K ﹤0.01% 6662
2014
Q2
$101K Sell
7,300
-8,700
-54% -$108K ﹤0.01% 6212
2014
Q1
$245K Buy
+16,000
New +$228K ﹤0.01% 5278

Other funds holding GALT